East Bay's Scribe Therapeutics lands 2nd big deal with Sanofi, this one aimed initially at sickle cell disease
San Francisco Business Times
|
July 18, 2023
X min read
San Francisco Business Times
|
July 18, 2023
Share on Social
More like this
Media
Another proof point from CIRM-supported research
October 7, 2026
California Institute for Regenerative Medicine
Read Now
Press
Another proof point from CIRM-supported research
October 7, 2026
California Institute for Regenerative Medicine
Read Now
